Please login to the form below

Not currently logged in
Email:
Password:

James D'Arecca joins Actavis

Moves from Bausch & Lomb to take up accounting role

James D'Arecca has moved from eyecare firm Bausch & Lomb to join generic company Actavis as its new chief accounting officer.

He served in a similar role at Bausch & Lomb and in his new position will report to Actavis' chief financial officer R Todd Joyce.

Prior to Bausch & Lomb, he worked for Merck & Co, where he served as executive director and business development controller.

In this role, he was the primary liaison between the controller's organisation and the business development and corporate licensing functions.

Prior to joining Merck, D'Arecca was executive director and assistant controller at Schering-Plough, which Merck acquired in 2009.

His career to date has also included 13 years with PricewaterhouseCoopers, where his industry focus was on pharmaceuticals, medical devices and consumer products.

20th August 2013

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics